4151 - 4200 of 8816 Results
Title
Year
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease2015OPENTitle: CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson DiseaseJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 58Issue #: 1Start Page: 88End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12031-015-0647-xBest OA location URL: http://doi.org/10.1007/s12031-015-0647-xCitation Count: 90
-
RESTRICTEDTitle: Effect of sex on aging-related decline of dopamine transporter in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 1Start Page: 76End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-020-01538-8Citation Count: 7
-
OPENTitle: Functional Connectivity-Based Modelling Simulates Subject-Specific Network Spreading Effects of Focal Brain StimulationJournal Name: Neuroscience BulletinPublisher: Springer Science and Business Media LLCVol: 34Issue #: 6Start Page: 921End Page: 938Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12264-018-0256-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12264-018-0256-0.pdfCitation Count: 13
-
OPENTitle: Progressive brain atrophy in chronically infected and treated HIV+ individualsJournal Name: Journal of NeuroVirologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 3Start Page: 342End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13365-019-00723-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6635004Citation Count: 36
-
RESTRICTEDTitle: Diagnosis of Parkinson’s Disease at an Early Stage Using Volume Rendering SPECT Image SlicesJournal Name: Arabian Journal for Science and EngineeringPublisher: Springer Science and Business Media LLCVol: 45Issue #: 4Start Page: 2799End Page: 2811Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13369-019-04152-7Citation Count: 12
-
OPENTitle: The Promise and Pitfalls of Facebook Advertising: a Genetic Counselor's PerspectiveJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 2Start Page: 326End Page: 328Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0207-3Citation Count: 5
-
RESTRICTEDTitle: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging FeaturesJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 6Start Page: 1165End Page: 1173Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11307-019-01334-5Citation Count: 47
-
OPENTitle: Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer’s disease to Parkinson’s diseaseJournal Name: International Journal of Computer Assisted Radiology and SurgeryPublisher: Springer Science and Business Media LLCVol: 18Issue #: 5Start Page: 809End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11548-023-02866-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11548-023-02866-6.pdfCitation Count: 14
-
OPENTitle: Morphological analysis of subcortical structures for assessment of cognitive dysfunction in Parkinson’s disease using multi-atlas based segmentationJournal Name: Cognitive NeurodynamicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 5Start Page: 835End Page: 845Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11571-021-09671-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8448821Citation Count: 10
-
RESTRICTEDTitle: Reduced gray matter volume in cognitively preserved COMT 158Val/Val Parkinson’s disease patients and its association with cognitive declineJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 14Issue #: 2Start Page: 321End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-018-0022-yCitation Count: 15
- Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder2018OPENTitle: Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorderJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 13Issue #: 5Start Page: 1352End Page: 1360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11682-018-9939-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-018-9939-4.pdfCitation Count: 31
-
RESTRICTEDTitle: Active information storage in Parkinson’s disease: a resting state fMRI study over the sensorimotor cortexJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 14Issue #: 4Start Page: 1143End Page: 1153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-019-00037-3Citation Count: 9
-
OPENTitle: Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 5Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09250-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09250-y.pdfCitation Count: 18
-
RESTRICTEDTitle: The exploration of Parkinson’s disease: a multi-modal data analysis of resting functional magnetic resonance imaging and gene dataJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page: 1986End Page: 1996Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-020-00392-6Citation Count: 11
-
OPENTitle: Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohortJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 8Start Page: 1927End Page: 1936Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09348-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09348-3.pdfCitation Count: 207
-
OPENTitle: Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 1Start Page: 337End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-10163-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7855683Citation Count: 15
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 43
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 30
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 27
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 62
- Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?2023OPENTitle: Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?Journal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 22Issue #: 10Start Page: 1583End Page: 1605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1570159x21666230801140648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11284713Citation Count: 1
-
OPENTitle: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is PresentJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 157End Page: 160Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20159Best OA location URL: https://doi.org/10.14802/jmd.20159Citation Count: 10
-
RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
OPENTitle: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 19Start Page: 1944End Page: 1950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9aBest OA location URL: https://n.neurology.org/content/neurology/79/19/1944.full.pdfCitation Count: 151
-
OPENTitle: Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 15Start Page: 1283End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016Best OA location URL: https://n.neurology.org/content/neurology/85/15/1283.full.pdfCitation Count: 27
-
RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 17
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 19
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Citation Count: 13
-
OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 8
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 9
-
OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 10
-
RESTRICTEDTitle: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System AtrophyJournal Name: NeurosciencePublisher: Elsevier BVVol: 459Issue #:Start Page: 142End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003Citation Count: 4
-
RESTRICTEDTitle: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat ModelJournal Name: NeurosciencePublisher: Elsevier BVVol: 460Issue #:Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019Citation Count: 6
-
RESTRICTEDTitle: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common MarmosetJournal Name: NeurosciencePublisher: Elsevier BVVol: 480Issue #:Start Page: 143End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009Citation Count: 9
-
RESTRICTEDTitle: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic NeuronsJournal Name: NeurosciencePublisher: Elsevier BVVol: 506Issue #:Start Page: 114End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011Citation Count: 1
-
RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 9
-
OPENTitle: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 7End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdfCitation Count: 5
-
OPENTitle: Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 16End Page: 23Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.010Best OA location URL: http://www.prd-journal.com/article/S1353802020308609/pdfCitation Count: 42
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
RESTRICTEDTitle: Essential tremor and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 125End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012Citation Count: 3
-
OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 17
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
RESTRICTEDTitle: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 128End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011Citation Count: 0
-
RESTRICTEDTitle: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 66End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004Citation Count: 11
-
RESTRICTEDTitle: Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 82End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.024Citation Count: 2
-
OPENTitle: Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.001Citation Count: 9
-
OPENTitle: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 95End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031Citation Count: 14
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8